Bydureon 2 mg single-dose pen Images
Generic Name: exenatide
This medication has been identified as Bydureon 2 mg single-dose pen. It is supplied by AstraZeneca.
Bydureon is used in the treatment of Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Risk cannot be ruled out during pregnancy. Bydureon 2 mg single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Bydureon
- Generic Name
- exenatide
- Strength
- 2 mg single-dose pen
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-6530 (Discontinued)
More about Bydureon (exenatide)
- Check interactions
- Compare alternatives
- Reviews (270)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.